Skip to main content
Top
Published in: Experimental Hematology & Oncology 1/2017

Open Access 01-12-2017 | Case report

Metastatic squamous cell carcinoma of colon from esophageal cancer

Authors: Natasha Garg, Constance Stoehr, Yan Shi Zhao, Heather Rojas, Chung-Tsen Hsueh

Published in: Experimental Hematology & Oncology | Issue 1/2017

Login to get access

Abstract

Background

Esophageal cancer including squamous cell carcinoma (SCC) and adenocarcinoma represents 4% of all cancers in the United States. Patients with esophageal cancer frequently present with locally advanced disease, and about 40% of patients have evidence of metastatic disease on presentation. Common sites of metastasis include liver, lung and bone. Here, we present a rare case of colonic metastasis from primary esophageal SCC.

Case presentation

A 60-year-old Caucasian male with a history of 20-pack-year cigarette smoking received surgery and adjuvant chemoradiotherapy for locally advanced SCC of larynx. Approximately 9 months later, he developed dysphagia, and found to have a esophageal SCC in the mid-esophagus with regional lymph node involvement. He underwent chemoradiation treatment with good response and improved symptoms but declined subsequent surgical resection for esophageal cancer. About 1 year after the diagnosis of esophageal cancer, he developed blood streaked bowel movement and severe anemia. Colonoscopy showed a 3-cm mass in the proximal ascending colon; biopsy showed metastatic SCC, consistent with metastasis from esophageal primary. He subsequently received palliative radiation to the ascending colon metastatic tumor with improvement of anemia, and remained transfusion independent for more than 3 months.

Conclusions

Colonic metastasis from esophageal SCC is rare, and associated with poor prognosis. There are no definite features in terms of location, histological differentiation etc. that contribute to colonic metastasis from primary esophageal SCC. The goal of treatment is palliative and data from our and other case reports support the use of chemotherapy and radiation for symptom improvement and disease control.
Literature
1.
2.
go back to reference Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12.CrossRefPubMed Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12.CrossRefPubMed
3.
go back to reference Zhang Y. Epidemiology of esophageal cancer. W J Gastroenterol. 2013;19(34):5598–606.CrossRef Zhang Y. Epidemiology of esophageal cancer. W J Gastroenterol. 2013;19(34):5598–606.CrossRef
4.
go back to reference Quint LE, Hepburn LM, Francis IR, Whyte RI, Orringer MB. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer. 1995;76(7):1120–5.CrossRefPubMed Quint LE, Hepburn LM, Francis IR, Whyte RI, Orringer MB. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer. 1995;76(7):1120–5.CrossRefPubMed
5.
go back to reference Gao X, Fisher SG, Mohideen N, Emami B. Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol. 2003;56(2):427–35.CrossRef Gao X, Fisher SG, Mohideen N, Emami B. Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol. 2003;56(2):427–35.CrossRef
6.
go back to reference Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963–8.CrossRefPubMed Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963–8.CrossRefPubMed
7.
go back to reference Sabharwal R, Mahendra A, Moon NJ, Gupta P, Jain A, Gupta S. Genetically altered fields in head and neck cancer and second field tumor. South Asian J Cancer. 2014;3(3):151–3.CrossRefPubMedPubMedCentral Sabharwal R, Mahendra A, Moon NJ, Gupta P, Jain A, Gupta S. Genetically altered fields in head and neck cancer and second field tumor. South Asian J Cancer. 2014;3(3):151–3.CrossRefPubMedPubMedCentral
8.
go back to reference Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, Fu KK, Cooper JS, Vokes EE, Chamberlain RM, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomark Prev. 2001;10(8):823–9. Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, Fu KK, Cooper JS, Vokes EE, Chamberlain RM, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomark Prev. 2001;10(8):823–9.
9.
go back to reference Benner SE, Pajak TF, Lippman SM, Earley C, Hong WK. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J Natl Cancer Inst. 1994;86(2):140–1.CrossRefPubMed Benner SE, Pajak TF, Lippman SM, Earley C, Hong WK. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J Natl Cancer Inst. 1994;86(2):140–1.CrossRefPubMed
10.
go back to reference Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990;323(12):795–801.CrossRefPubMed Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990;323(12):795–801.CrossRefPubMed
11.
go back to reference Halimi C, Barry B, De Raucourt D, Choussy O, Dessard-Diana B, Hans S, Lafarge D, work-group S: Guidelines of the French Society of Otorhinolaryngology (SFORL), short version. Diagnosis of local recurrence and metachronous locations in head and neck oncology. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132(5):287–90.CrossRefPubMed Halimi C, Barry B, De Raucourt D, Choussy O, Dessard-Diana B, Hans S, Lafarge D, work-group S: Guidelines of the French Society of Otorhinolaryngology (SFORL), short version. Diagnosis of local recurrence and metachronous locations in head and neck oncology. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132(5):287–90.CrossRefPubMed
12.
go back to reference van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84.CrossRefPubMed van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84.CrossRefPubMed
13.
go back to reference Herskovic A, Russell W, Liptay M, Fidler MJ, Al-Sarraf M. Esophageal carcinoma advances in treatment results for locally advanced disease: review. Ann Oncol. 2012;23(5):1095–103.CrossRefPubMed Herskovic A, Russell W, Liptay M, Fidler MJ, Al-Sarraf M. Esophageal carcinoma advances in treatment results for locally advanced disease: review. Ann Oncol. 2012;23(5):1095–103.CrossRefPubMed
15.
go back to reference Stewart SL, Wike JM, Kato I, Lewis DR, Michaud F. A population-based study of colorectal cancer histology in the United States, 1998–2001. Cancer. 2006;107(5 Suppl):1128–41.CrossRefPubMed Stewart SL, Wike JM, Kato I, Lewis DR, Michaud F. A population-based study of colorectal cancer histology in the United States, 1998–2001. Cancer. 2006;107(5 Suppl):1128–41.CrossRefPubMed
16.
go back to reference Tessier DJ, McConnell EJ, Young-Fadok T, Wolff BG. Melanoma metastatic to the colon: case series and review of the literature with outcome analysis. Dis Colon Rectum. 2003;46(4):441–7.CrossRefPubMed Tessier DJ, McConnell EJ, Young-Fadok T, Wolff BG. Melanoma metastatic to the colon: case series and review of the literature with outcome analysis. Dis Colon Rectum. 2003;46(4):441–7.CrossRefPubMed
17.
go back to reference Stinchcombe TE, Socinski MA, Gangarosa LM, Khandani AH. Lung cancer presenting with a solitary colon metastasis detected on positron emission tomography scan. J Clin Oncol. 2006;24(30):4939–40.CrossRefPubMed Stinchcombe TE, Socinski MA, Gangarosa LM, Khandani AH. Lung cancer presenting with a solitary colon metastasis detected on positron emission tomography scan. J Clin Oncol. 2006;24(30):4939–40.CrossRefPubMed
18.
go back to reference Lee HC, Yang MT, Lin KY, Tu HY, Zhang TA, Chen PH. Metastases from gastric carcinoma to colon in the form of multiple flat elevated lesions: a case report. Kaohsiung J Med Sci. 2004;20(11):552–7.CrossRefPubMed Lee HC, Yang MT, Lin KY, Tu HY, Zhang TA, Chen PH. Metastases from gastric carcinoma to colon in the form of multiple flat elevated lesions: a case report. Kaohsiung J Med Sci. 2004;20(11):552–7.CrossRefPubMed
19.
go back to reference Karwasra RK, Garg P, Godara R, Yadav V. Colonic metastasis from squamous cell carcinoma of esophagus. Indian J Gastroenterol. 2002;21(5):207.PubMed Karwasra RK, Garg P, Godara R, Yadav V. Colonic metastasis from squamous cell carcinoma of esophagus. Indian J Gastroenterol. 2002;21(5):207.PubMed
20.
go back to reference Iwase H, Indo T, Shimada M, Tsuzuki T, Nakarai K, Kaida S, Doi R, Okeya M, Kato E. Esophageal cancer with colonic metastasis successfully treated by chemoradiotherapy followed by chemotherapy with S-1 and cisplatin. Int J Clin Oncol. 2004;9(5):398–402.CrossRefPubMed Iwase H, Indo T, Shimada M, Tsuzuki T, Nakarai K, Kaida S, Doi R, Okeya M, Kato E. Esophageal cancer with colonic metastasis successfully treated by chemoradiotherapy followed by chemotherapy with S-1 and cisplatin. Int J Clin Oncol. 2004;9(5):398–402.CrossRefPubMed
21.
go back to reference Shimada Y, Okumura T, Hojo S, Sukegawa K, Nagata T, Hayashi S, Tsukada K. Synchronous asymptomatic colonic metastasis from primary esophageal squamous cell carcinoma. J Surg Case Rep. 2014;2014(1):117.CrossRef Shimada Y, Okumura T, Hojo S, Sukegawa K, Nagata T, Hayashi S, Tsukada K. Synchronous asymptomatic colonic metastasis from primary esophageal squamous cell carcinoma. J Surg Case Rep. 2014;2014(1):117.CrossRef
22.
go back to reference Oshiro H, Osaka Y, Tachibana S, Aoki T, Tsuchiya T, Nagao T. Retrograde lymphatic spread of esophageal cancer: a case report. Medicine. 2015;94(27):e1139.CrossRefPubMedPubMedCentral Oshiro H, Osaka Y, Tachibana S, Aoki T, Tsuchiya T, Nagao T. Retrograde lymphatic spread of esophageal cancer: a case report. Medicine. 2015;94(27):e1139.CrossRefPubMedPubMedCentral
23.
go back to reference Higuchi K, Koizumi W, Tanabe S, Sasaki T, Katada C, Azuma M, Nakatani K, Ishido K, Naruke A, Ryu T. Current management of esophageal squamous-cell carcinoma in Japan and other countries. Gastrointest Cancer Res. 2009;3(4):153–61.PubMedPubMedCentral Higuchi K, Koizumi W, Tanabe S, Sasaki T, Katada C, Azuma M, Nakatani K, Ishido K, Naruke A, Ryu T. Current management of esophageal squamous-cell carcinoma in Japan and other countries. Gastrointest Cancer Res. 2009;3(4):153–61.PubMedPubMedCentral
24.
go back to reference Ajani JA, Barthel JS, Bentrem DJ, D’Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, et al. Esophageal and esophagogastric junction cancers. J Natl Compr Cancer Netw. 2011;9(8):830–87. Ajani JA, Barthel JS, Bentrem DJ, D’Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, et al. Esophageal and esophagogastric junction cancers. J Natl Compr Cancer Netw. 2011;9(8):830–87.
25.
26.
go back to reference Piha-Paul SA, Jalal SI, Mai-Dang H, Saraf S, Koshiji M, Csiki I, Bennouna J. Updated results for the advanced esophageal carcinoma cohort of the phase Ib KEYNOTE-028 study of pembrolizumab (MK-3475). J Clin Oncol. 2016;34(4_suppl):7.CrossRef Piha-Paul SA, Jalal SI, Mai-Dang H, Saraf S, Koshiji M, Csiki I, Bennouna J. Updated results for the advanced esophageal carcinoma cohort of the phase Ib KEYNOTE-028 study of pembrolizumab (MK-3475). J Clin Oncol. 2016;34(4_suppl):7.CrossRef
Metadata
Title
Metastatic squamous cell carcinoma of colon from esophageal cancer
Authors
Natasha Garg
Constance Stoehr
Yan Shi Zhao
Heather Rojas
Chung-Tsen Hsueh
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Experimental Hematology & Oncology / Issue 1/2017
Electronic ISSN: 2162-3619
DOI
https://doi.org/10.1186/s40164-017-0069-2

Other articles of this Issue 1/2017

Experimental Hematology & Oncology 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine